Hester Biosciences Ltd Q4 FY2022 consolidated profit at Rs. 9 crores

Hester Biosciences Limited has reported Consolidated financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 63.661 crores during the period ended March 31, 2022 as compared to Rs. 58.466 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. 9.007 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 8.330 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. 10.59 for the period ended March 31, 2022 as compared to Rs. 9.79 for the period ended December 31, 2021.

Financials	Q4 FY2022	Q3 FY2022	% Change
Total Income	₹ 63.661 crs	₹58.466 crs	8.89%
Net Profit	₹9.007 crs	₹8.330 crs	8.13%
EPS	₹10.59	₹9.79	8.17%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 63.661 crores during the period ended March 31, 2022 as compared to Rs.66.651 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.9.007 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.10.098 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.10.59 for the period ended March 31, 2022 as compared to Rs.11.87 for the period ended March 31, 2021.

Financials	Q4 FY2022	Q4 FY2021	% Change
Total Income	₹ 63.661 crs	₹66.651 crs	-4.49%
Net Profit	₹9.007 crs	₹10.098 crs	-10.80%
EPS	₹10.59	₹11.87	-10.78%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.248.747 crores during the Financial Year ended March 31, 2022 as compared to Rs.219.016 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.39.484 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.34.698 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.46.41 for the Financial Year ended March 31, 2022 as compared to Rs.40.79 for the Financial Year ended March 31, 2021.

Financials	Year Ended FY2022	Year Ended FY2021	% Change
Total Income	₹248.747 crs	₹219.016 crs	13.57%
Net Profit	₹39.484 crs	₹34.698 crs	13.79%
EPS	₹46.41	₹40.79	13.78%

Shares of Hester Biosciences Limited was last trading in BSE at Rs. 2341.25 as compared to the previous close of Rs. 2444.10. The total number of shares traded during the day was 202 in over 74 trades.

The stock hit an intraday high of Rs. 2420.30 and intraday low of 2311.00. The net turnover during the day was Rs. 481713.00.

Source : Equity Bulls

Keywords

HesterBiosciences Q4FY22 FY2022 ResultUpdate